AK Dwivedi - Neural Computing and Applications, 2018 - Springer
Microarray gene expression profile shall be exploited for the efficient and effective classification of cancers. This is a computationally challenging task because of large …
ML den Boer, R Pieters - Current Drug Targets, 2007 - ingentaconnect.com
The efficacy of current treatment protocols for childhood cancer is mainly based on empirical studies by adding drugs, changing drug dosages and changing drug combinations. In …
RA O'Leary, RW Francis, KW Carter… - Proc. 18th World …, 2009 - academia.edu
Recently, microarrays technologies have been extensively used to distinguish gene expression in acute lymphoblastic leukaemia (ALL)(eg Pui et al., 2004; Hoffmann et al …
K Hoffmann, MJ Firth, AH Beesley, NH de Klerk… - BMC cancer, 2006 - Springer
Background Recent findings from microarray studies have raised the prospect of a standardized diagnostic gene expression platform to enhance accurate diagnosis and risk …
Acute lymphoblastic leukemia (ALL) is a heterogeneous group of white blood cell malignancies. Though a number of clinical and biological prognostic factors have been …
A Angelakis, I Soulioti, M Filippakis - Heliyon, 2023 - cell.com
We define an iterative method for dimensionality reduction using categorical gradient boosted trees and Shapley values and created four machine learning models which …
M Yazdanparast, R Sheikhpour… - Iranian Journal of …, 2024 - publish.kne-publishing.com
Background: Microarray technology enables the examination of gene expression in thousands of genes and can be highly effective in identifying various types of cancers …
SH Bouazza, L Wakrim… - 2023 IEEE 3rd …, 2023 - ieeexplore.ieee.org
The development of Microarray technology has provided vast amounts of data in various fields, including a cancer database which plays a crucial role in cancer prediction and …
WL Tung, C Quek - Artificial intelligence in medicine, 2005 - Elsevier
OBJECTIVE:: Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood, representing nearly one third of all pediatric cancers. Currently, the treatment of …